← Browse by Condition
Medical Condition

richter s transformation

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1, Phase 2
NCT06043674 Phase 2
Recruiting

Phase 2 Study of Glofitamab Monotherapy & With Polatuzumab Vedotin, Pirtobrutinib, or Atezolizumab in Richter's Transformation

Enrollment
70 pts
Location
United States
Sponsor
Christine Ryan
View Trial →
NCT05294731 Phase 1, Phase 2
Recruiting

Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader

Enrollment
146 pts
Location
China
Sponsor
BeiGene
View Trial →